A Phase I Trial of IRS-1 HSV C134 Administered Intratumorally in Patients with Recurrent Malignant Glioma


Total Award Amount

  • 798311.00
  • Direct Costs

  • 798311.00
  • Sponsor Award Id

  • G-17-1400
  • Contributor

  • C. Ryan Miller   Investigator  
  • Caitlin Dalgo MSN, BSN, RN, MSN, CRNP, AGACNP-BC, RNFA   Investigator  
  • Gary Cutter   Investigator  
  • Inmaculada Aban   Investigator  
  • James Markert M.D., M.P.H.   Principal Investigator  
  • Jianmei Leavenworth Ph.D.   Investigator  
  • Louis Nabors M.D.   Investigator  
  • Philip Schmalz   Investigator